Searchable abstracts of presentations at key conferences in endocrinology

ea0055we14 | Workshop E: Disorders of the adrenal gland | SFEEU2018

Hyporeninaemic hypoaldosteronism in surgically cured Conn’s syndrome

Pittaway James , Coppack Simon , Carpenter Rob , Drake William

A 53 year old gentleman from Ghana was referred to our clinic for further management of his Conn’s syndrome. This had been diagnosed at another hospital 3 years previously when he presented with hypertension and hypokalaemia on the back of 14 years of poorly controlled hypertension. Serum aldosterone was raised at 3178 pmol/l and serum renin mass was 3.9 mU/l. MRI revealed a 5 mm nodule in the medial limb of the right adrenal gland. He was initially commenced on medical t...

ea0090ep31 | Adrenal and Cardiovascular Endocrinology | ECE2023

Exploring experiences of patients with Adrenal insufficiency (AI) in managing adrenal crisis using parenteral hydrocortisone: A qualitative study

Chua Aldons , Cartwright Martin , Drake William , Llahana Sofia

Background: Adrenal insufficiency (AI) poses a significant health burden on patients, their families, and the healthcare system. Cost of illness for this patient population is four times higher than the general population. Hospital admissions due to adrenal crisis (AC) form a considerable proportion of this cost. Almost 1 in 200 patients die from AC. One in 12 patients with AI are hospitalised at least once a year following an acute AC episode if not treated promptly with pare...

ea0091oc5 | Oral Communications | SFEEU2023

The success story of Osilodrostat for optimisation of severe Cushing’s Disease

Subramaniam Yuvanaa , Dorward Neil , Drake William M , Brooke Antonia M

A 51-year-old gentleman presented in June 2022 with pneumobilia, staph liver abscesses and rapidly conducted atrial fibrillation requiring ITU admission. He had a 2-year history of typical Cushingoid features and hypogonadism, 4 agent hypertension since 2012, fragility fractures, previous renal calculi, pulmonary emboli and diabetes. He had not been able to walk unaided for a year (was mobilising with crutches on admission). In retrospect, he had previously had a cortisol of 7...

ea0069oc6 | Oral Communications | SFENCC2020

MGES: Monoclonal Gammopathy of Endocrine Significance?

Ratnayake Gowri , Church David , Semple Robert , Cavenagh James , Drake William

A 65 year-old male was evaluated at another hospital for frequent episodes of fainting preceded by sweating, palpitations fatigue and hunger over several years. There was no personal or family history of diabetes mellitus. Hypoglycaemia was confirmed on a supervised fast and, guided by some equivocal uptake on a dotatate scan, he underwent a distal pancreatectomy, but the symptoms persisted. He was referred to our centre. He reported relentless weight gain and a need to eat po...

ea0065oc5.6 | Adrenal and Cardiovascular | SFEBES2019

SLC35F1, a potential marker for aldosterone producing cell clusters

Goodchild Emily , Linton Kenneth , Drake William , Brown Morris

Background: Aldosterone producing cell clusters (APCCs) are microscopic pockets of cells in the adrenal zona glomerulosa (ZG), which stain densely for aldosterone synthase (CYP11B2). They exist in 30% of normal adrenal glands and have similar somatic genetic mutations as some aldosterone producing adenomas (APA), especially of CACNA1D. Some APCCs are precursors to APAs. Adrenalectomy for primary aldosteronism (PA) cures hypertension in < 50% of patients, maybe bec...

ea0065op2.1 | Thyroid | SFEBES2019

Day case radio-iodine for remnant ablation in differentiated thyroid cancer patients is safe and helps reduce bed pressures in a busy tertiary centre hospital

Rowse Victoria , Hussain Shazia , Trahair Emily , Drake William , Siddiqi Ayesha

The amount of radioactivity given to patients undergoing ablation for remnant tissue in thyroid cancer at our centre has been greatly reduced to 1100 MBq I-131 in recent years, prompting a review of practice. An extensive risk assessment, focusing particularly on radiation exposure to the public during the patient’s commute home was conducted and found patients could now be discharged safely on the day of treatment. Owing to these findings and audit showing 86% of patient...

ea0048wd7 | Workshop D: Disorders of the adrenal gland | SFEEU2017

Cushing’s disease – the potential pitfalls of adrenal autonomy

Bolding Nathalie , Gorrigan Rebecca , Shaho Shang , Drake William

A 54-year-old female presented to her GP with a 9-year history of poorly controlled hypertension (requiring five drugs) and type 2 diabetes mellitus, associated with central weight gain, low mood and poor wound healing. On examination she had clinical evidence of glucocorticoid excess. Cushing’s syndrome was confirmed on low dose dexamethasone suppression testing (2+0 cortisol 857 nmol/l, 2+48 cortisol 346 nmol/l). Cushing’s day curve demonstrated loss of circadian r...

ea0044p136 | Neoplasia, cancer and late effects | SFEBES2016

The role of primary cilia in the molecular pathogenesis of phaeochromocytoma

O'Toole Sam , Srirangalingam Umasuthan , Drake William , Chapple Paul

Phaeochromocytomas are life-threatening catecholamine-producing tumours of the adrenal medulla. Our understanding of their pathogenesis is incomplete, with limited ability to predict malignant potential and disappointing treatment results in disseminated disease. Phaeochromocytomas occur in the inherited cancer syndrome von Hippel-Lindau (VHL). One function of VHL protein is in the formation and maintenance of primary cilia. These are microtubule-based organelles that protrude...

ea0041gp1 | Adrenal | ECE2016

The role of primary cilia in the molecular pathogenesis of phaeochromocytoma

O'Toole Samuel , Srirangalingam Umasuthan , Drake William , Chapple J Paul

Phaeochromocytomas are neuroendocrine tumours arising from adrenal medulla chromaffin cells. They are life threatening due to adrenaline and noradrenaline release and potential for metastatic spread. Understanding of phaeochromocytoma pathogenesis is incomplete with limited ability to predict malignant potential. Additionally, once metastatic, response to conventional therapies is disappointing.Phaeochromocytomas are a common feature of the inherited can...

ea0059ep83 | Neuroendocrinology and pituitary | SFEBES2018

A disappearing act in the pituitary fossa with recovery from panhypopituitarism

Goodchild Emily , Evanson Jane , Drake William , Glynn Nigel

A 36-year-old, previously healthy, man presented with several weeks’ history of gradually worsening headache. He attended A&E after he was woken by sudden worsening of the headache, associated with vomiting and pre-syncopal symptoms. Investigations revealed severe hyponatraemia - serum Na 109 mmol/L. He was also severely hypocortisolaemic – serum cortisol (random) 16 nmol/L, ACTH 19 ng/L. Cranial imaging revealed a 17 mm suprasellar, complex cystic pituitary lesi...